 |
 |
||||||||||||||
 |
 |
 |
 |
 |
|||||||||||
|
|||||||||||||||
Psoriasis Treatment | Psoriasis Cream News
Psoriasis Treatment and Psoriasis Research in the News
If you have Psoriasis you may want to try our calming and hydrating products. Learn more here.Latest News Hi-Tech Pharmacal gets FDA OK for scalp psoriasis treatment March 23 (Reuters) - Hi-Tech Pharmacal Co. Inc. (HITK.O: Quote, Profile, Research) said the U.S. Food and Drug Administration has granted it tentative approval for the generic version of Warner Chilcott Ltd.'s (WCRX.O: Quote, Profile, Research) treatment for psoriasis of the scalp. Hi-Tech does not plan to market its topical solution, Calcipotriene, till the expiration of Warner Chilcott's patent due on Dec. 29, 2007, the company said in a statement. (Reporting by Sweta Singh in Bangalore) Cytochroma completes enrollment in Phase II psoriasis trial MARKHAM, ON, March 6 /PRNewswire/ -- Cytochroma Inc. announced today that it has completed the enrollment of patients in a Phase II clinical trial of CTA018 Cream for chronic plaque psoriasis. The ongoing Phase II trial is a randomized, double-blind, placebo-controlled study being conducted in 16 dermatology clinics located throughout the continental United States. A total of 147 subjects with chronic plaque psoriasis have been enrolled and are undergoing a 12-week course of treatment with one of three different concentrations of CTA018 Cream or a matching placebo. All subjects are receiving once daily topical treatment over a maximum of 15% body surface area. The primary efficacy endpoint of the trial is the Physician Static Global Assessment, which is a commonly used psoriasis severity assessment scale required by the United States Food and Drug Administration. Medarex Announces Initiation Of Phase I Clinical Trial. Medarex, Inc. (Nasdaq: MEDX) announced today that its partner MedImmune, Inc. has initiated a Phase I clinical trial of MEDI-545 for the potential treatment of psoriasis. MEDI-545 is a fully human antibody generated by Medarex's UltiMAb Human Antibody Development System(R). UV light treatment helps skin diseases CEDAR RAPIDS - That extra hour of sunshine is here. Studies show it's great for your mood. But UV light can also help treat certain skin diseases.To the untrained eye, Christy Kolder looks like she's trying to get a tan. But actually, she's clearing up a skin disease that's plagued her since elementary school."It's not fun, it can be a little intimidating to wear short sleeve shirts or even shorts because even if you get used to them, you can be a little self conscious because people can see it. It's very noticeable," said Kolder.It is psoriasis, red lesions like these that covered her elbows, knees and shins. Psoriasis occurs when skin cells multiply too fast.When medication didn't work Christy tried UV light therapy at Mercy Care North.In just a few treatments, her skin started to look normal again."The UV light slows down that process, changes the cells functions and reduces that process and takes the lesion away," said David Neira, a physical therapist at Mercy.Most patients get treatment about two to three times a week and typically spend no more than five minutes in the booth. Additional information and updates can be found on these Web sites. American Academy of Dermatology This national professional association for dermatologists has a Web site (PsoriasisNet) that contains basic information on psoriasis for lay readers. Also included are press releases, answers to frequently asked questions, information updates, and lists of dermatologists. National Psoriasis Foundation The National Psoriasis Foundation provides physician referrals and publishes pamphlets and newsletters that include information on support groups, research, and new drugs and other treatments. The foundation also promotes community awareness of psoriasis.
|
